检索结果 - Vivek Abraham
- Showing 1 - 2 results of 2
-
1
-
2
The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i> 由 Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard A. Liu, Michael J. Mitten, Paul Nimmer, Xiaoyu Lin, Morey L. Smith, Yu Shen, Alexander R. Shoemaker, Stephen K. Tahir, Haichao Zhang, Scott Ackler, Saul H. Rosenberg, Heather Maecker, Deepak Sampath, Joel D. Leverson, Chris Tse, Steven W. Elmore
出版 2011Artigo
相关主题
Apoptosis
Biochemistry
Biology
Cancer research
In vitro
In vivo
Pharmacology
Biotechnology
Blood–brain barrier
Bortezomib
Cancer
Carfilzomib
Central nervous system
Chemistry
Docetaxel
Downregulation and upregulation
Epidermal growth factor receptor
Erlotinib
Gene
Genetics
Glioma
Immunology
Internal medicine
Medicine
Molecular biology
Multiple myeloma
Proteasome
Proteasome inhibitor